Incyte Corp. Stock Underperforms Wednesday When Compared To CompetitorsMarketWatch Automated·4 hours agoINCY-2.18%
Revolution Medicines to report Q2 financial results after market close, hosts webcast updatePUBT·5 hours agoRVMD-1.60%
Biotech Stocks At 52-Week Highs - INCY Rises With Q2 Results, PLSE, SI, BVS, LBRXrttnews·17 hours agoBVS-0.68%LBRX+11.62%
James Michael Morrissey Expands Holdings With $54K Incyte Stock Options Acquisitionbenzinga_article·1 day ago, 10:00 AMINCY-2.18%
ServiceNow, Meta, eBay And A Health Care Stock On CNBC’s ‘Final Trades’benzinga_article·1 day ago, 07:18 AMNOW+4.65%INCY-2.18%
INCY: Q2 2026 revenue grew 38% year-over-year, driven by strong sales and a one-time Opzelura benefitQuartr·1 day ago, 06:18 AMINCY-2.18%
Incyte | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 1.674 BEarnings Watch·1 day ago, 06:04 AMINCY-2.18%
Incyte Corp. Stock Underperforms Monday When Compared To Competitors Despite Daily GainsMarketWatch Automated·2 days ago, 04:03 PMINCY-2.18%
